2019
DOI: 10.1038/s41467-019-11951-x
|View full text |Cite
|
Sign up to set email alerts
|

Defects in t6A tRNA modification due to GON7 and YRDC mutations lead to Galloway-Mowat syndrome

Abstract: N 6 -threonyl-carbamoylation of adenosine 37 of ANN-type tRNAs (t 6 A) is a universal modification essential for translational accuracy and efficiency. The t 6 A pathway uses two sequentially acting enzymes, YRDC and OSGEP, the latter being a subunit of the multiprotein KEOPS complex. We recently identified mutations in genes encoding four out of the five KEOPS subunits in children with Galloway-Mowat syndrome (GAMOS), a clinically heterogene… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
97
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 72 publications
(98 citation statements)
references
References 54 publications
1
97
0
Order By: Relevance
“…In humans, pathogenic mutations have been identified in all five KEOPS genes. These mutations give rise to Galloway-Mowat syndrome (GAMOS), a severe autosomalrecessive disease that manifests in developmental defects including renal dysfunction and microcephaly, leading to early childhood mortality [8][9][10] .…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…In humans, pathogenic mutations have been identified in all five KEOPS genes. These mutations give rise to Galloway-Mowat syndrome (GAMOS), a severe autosomalrecessive disease that manifests in developmental defects including renal dysfunction and microcephaly, leading to early childhood mortality [8][9][10] .…”
mentioning
confidence: 99%
“…Pcc1, which binds directly to Kae1, can mediate the dimerization of KEOPS 23,24 . However, this activity of Pcc1 is not required for t 6 A catalytic activity 24 and is obstructed in eukaryotes by Gon7 binding to Pcc1 7,8,25 . Remarkably, the Kae1 orthologs in bacteria and in the mitochondria reside in protein complexes that vary considerably in size and composition from KEOPS 14 .…”
mentioning
confidence: 99%
“…TsaEBD is a tRNA modification enzyme that is required for the synthesis of threonylcarbamoyl adenosine (t 6 A) (Thiaville et al, 2015;Zhang et al, 2015). t 6 A-modified tRNA is conserved in three domains of life and its deficiency sometimes causes severe dysfunctions (Thiaville et al, 2016;Arrondel et al, 2019;Ogura et al, 2019). In B. subtilis, several lines of evidence suggest a relationship between low t 6 A and protein quality control, including PDH (Ogura et al, 2019).…”
Section: Introductionmentioning
confidence: 99%
“… 4 , 5 Over the past years, 63 genes have been identified as causing monogenic forms of SRNS (recessive or dominant) in humans with an onset <25 years. 6 , 7 , 8 , 9 Characterization of the cellular function of these 63 genes helped delineate 12 distinct pathogenic pathways of SRNS/FSGS. 6 , 7 , 8 , 9 , 10 , 11 As these genes are mainly expressed in podocytes, gene identification has helped to reveal a central role of the podocyte in the pathogenesis of SRNS.…”
mentioning
confidence: 99%
“… 6 , 7 , 8 , 9 Characterization of the cellular function of these 63 genes helped delineate 12 distinct pathogenic pathways of SRNS/FSGS. 6 , 7 , 8 , 9 , 10 , 11 As these genes are mainly expressed in podocytes, gene identification has helped to reveal a central role of the podocyte in the pathogenesis of SRNS. 6 , 7 , 8 , 9 , 10 Monogenic causation accounts for 11.0% to 29.5% of patients with SRNS with onset before 25 years, 9 , 10 , 12 , 13 leaving up to 70% of cases in that age group genetically unsolved.…”
mentioning
confidence: 99%